MD Anderson Cancer Center again has been ranked No. 1 for cancer care by U.S. News & World Report’s annual “Best Hospitals” survey. Since the survey began in 1990, MD Anderson has been named one of the top two cancer hospitals, and it has ranked first 13 times in the past 16 years.
“To consistently be recognized for the quality and compassionate cancer care we provide patients who come to MD Anderson seeking our innovative approaches, world-renowned expertise and decades of experience is a true honor,” says Marshall Hicks, M.D., president ad interim.
Two MD Anderson subspecialties also received high rankings in the survey. In the Ear, Nose and Throat specialty, the institution’s Head and Neck Surgery service was No. 15, while Gynecologic Oncology and Reproductive Medicine came in No. 17 in the Gynecology category. The survey also ranked MD Anderson as “High Performing” in Diabetes & Endocrinology, Orthopedics and Urology.
MD Anderson’s commitment to patients and its mission to end cancer have driven the institution for more than 75 years and continue to fuel its efforts to improve the level of cancer care all over the world. Serving nearly 135,000 patients last year in the Texas Medical Center and throughout the Houston region, MD Anderson also extends its standard of care by collaborating with community hospitals and health systems around the world. Combined with other initiatives in prevention, research and education, MD Anderson’s outreach enables millions of local, domestic and international patients to have greater access to its expertise, experience and innovation.
“This recognition from U.S. News & World Report is a reminder that patients are at the center of all we do now and all we envision for the future,” says Stephen Hahn, M.D., deputy president and chief operating officer. “Our mission is bold, but it’s through innovative care, research, education and prevention that we will fulfill our promise to end cancer. It’s what we strive for every day.”
Read about the latest progress in Making Cancer History® in the Cancer Frontline blog.